Vivus (VVUS) will resume trading at 7:15AM after FDA approval
Tweet
Share
E-mailGet Alerts VVUS Hot Sheet
Join SI Premium – FREE
Vivus, Inc. (Nasdaq: VVUS) will resume trading at 7:15AM ET following FDA approval of obesity drug Qsymia.
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
